ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,646Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 300

$541K Total Retail Price of All Prescriptions

Rank: 39 out of 300

644 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 644 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 644 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 8,163 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $81 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 477 379 1 9
METFORMIN HCL 398 309 2 19
AMLODIPINE BESYLATE 389 341 3 2
PRAVASTATIN SODIUM 333 252 4 15
SIMVASTATIN 312 282 5 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 297 263 6 64
HYDROCHLOROTHIAZIDE 272 234 7 20
MELOXICAM 262 208 8 27
ZOLPIDEM TARTRATE 192 127 9 21
OMEPRAZOLE 186 146 10 11
GABAPENTIN 173 124 11 7
HYDROCODONE-ACETAMINOPHEN 172 126 S3 12 1
FUROSEMIDE 167 119 13 3
GLIMEPIRIDE 163 135 14 51
LISINOPRIL 150 105 15 4
SERTRALINE HCL 148 98 16 41
ATENOLOL 142 108 17 31
BISOPROLOL-HYDROCHLOROTHIAZIDE 131 89 18 285
FENOFIBRATE 126 87 19 98
SYNTHROID 119 119 20 49
ATORVASTATIN CALCIUM 116 108 21 14
CLOPIDOGREL 110 96 22 18
CITALOPRAM HBR 101 95 23 54
AMLODIPINE BESYLATE-BENAZEPRIL 101 75 23 52
TRAMADOL HCL 100 63 25 23
CRESTOR 99 65 26 26
LOSARTAN-HYDROCHLOROTHIAZIDE 98 69 27 97
NEXIUM 98 46 27 17
PANTOPRAZOLE SODIUM 96 66 29 35
METOPROLOL SUCCINATE 92 78 30 6
PLAVIX 92 75 30 24
ALPRAZOLAM 92 62 30 88
METOPROLOL TARTRATE 89 71 33 13
QUINAPRIL HCL 85 73 34 128
VERAPAMIL ER 83 76 35 113
LOSARTAN POTASSIUM 81 72 36 29
AMITRIPTYLINE HCL 79 70 R 37 66
CARVEDILOL 79 68 37 12
ESCITALOPRAM OXALATE 75 50 39 78
ALLOPURINOL 74 59 40 44
TIZANIDINE HCL 74 55 40 42
FLUOXETINE HCL 72 58 42 117
DOXAZOSIN MESYLATE 71 61 43 90
CIPROFLOXACIN HCL 70 51 44 28
TAMSULOSIN HCL 67 36 45 8
FELODIPINE ER 63 63 46 276
LEVOCETIRIZINE DIHYDROCHLORIDE 56 38 47 81
AMPHETAMINE SALT COMBO 56 15 S2 47 254
LOVASTATIN 55 43 49 68
ADVAIR DISKUS 54 21 50 60
BENAZEPRIL HCL 53 53 51 73
TRIAMTERENE-HCTZ 52 31 52 118
DIOVAN HCT 52 36 52 94
JANUVIA 51 28 54 100
PAROXETINE HCL 51 48 54 216
DIGOXIN 51 51 54 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.